NCT00008151View on ClinicalTrials.gov

Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2000

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
LeukemiaMyelodysplastic Syndromes
Interventions
DRUG

cyclosporine

DRUG

fludarabine phosphate

DRUG

gemtuzumab ozogamicin

DRUG

methotrexate

DRUG

mycophenolate mofetil

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00008151 - Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter